Literature DB >> 8803738

Efficacy of antibiotic prophylaxis for prevention of Lyme disease.

S Warshafsky1, J Nowakowski, R B Nadelman, R S Kamer, S J Peterson, G P Wormser.   

Abstract

OBJECTIVE: To determine if antibiotic prophylaxis following a dear tick bite is effective in reducing the risk of developing Lyme disease.
DESIGN: Meta-analysis of published trials. DATA IDENTIFICATION: Clinical trials were identified by a computerised literature search of MEDLINE and by an assessment of the bibliographies of published studies. STUDY SELECTION: Trials were included in the analysis if their patients were randomly allocated to a treatment or control group, enrolled within 72 hours following an Ixodes tick bite, and had no clinical evidence of Lyme disease at enrollment. Three trials were selected for review after inclusion criteria were applied. DATA EXTRACTION: Data were extracted for details of study design, patient characteristics, interventions, duration of therapy, and number of adverse events in each arm of therapy. RESULTS OF DATA SYNTHESIS: Among the 600 patients with Ixodes tick bites, the rate of infection in the placebo group was 1.4%. In contrast, patients who received antibiotic prophylaxis had a 0% infection rate. The pooled odds ratio, comparing prophylaxis to placebo, was 0.0 (95% confidence interval 0.0, 1.5) (p = .12).
CONCLUSIONS: The available evidence to date suggests that the routine use of antibiotic prophylaxis for the prevention of Lyme disease remains uncertain. Meta-analysis of the controlled trials failed to establish definitive treatment efficacy owing to the small sample size of the combined trials and the low rates of infection following a deer tick bite. A larger randomized trial is needed to demonstrate definitively that prophylaxis is more effective than placebo in reducing the risk of early Lyme disease in endemic areas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8803738     DOI: 10.1007/bf02600042

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  16 in total

1.  Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans.

Authors:  K Weber; V Preac-Mursic; U Neubert; R Thurmayr; P Herzer; B Wilske; G Schierz; W Marget
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

2.  Lyme disease--United States, 1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1994-08-12       Impact factor: 17.586

3.  Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease.

Authors:  R B Nadelman; S W Luger; E Frank; M Wisniewski; J J Collins; G P Wormser
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

4.  Ceftriaxone therapy of chronic inflammatory arthritis. A double-blind placebo controlled trial.

Authors:  E M Caperton; K L Heim-Duthoy; G R Matzke; P K Peterson; R C Johnson
Journal:  Arch Intern Med       Date:  1990-08

5.  Cefotaxime versus penicillin in the late stage of Lyme disease--prospective, randomized therapeutic study.

Authors:  D Hassler; L Zöller; M Haude; H D Hufnagel; F Heinrich; H G Sonntag
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

6.  Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans.

Authors:  K Hansen; A Hovmark; A M Lebech; K Lebech; I Olsson; L Halkier-Sørensen; E Olsson; E Asbrink
Journal:  Acta Derm Venereol       Date:  1992-08       Impact factor: 4.437

7.  Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis.

Authors:  H W Pfister; V Preac-Mursic; B Wilske; E Schielke; F Sörgel; K M Einhäupl
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

8.  A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites.

Authors:  E D Shapiro; M A Gerber; N B Holabird; A T Berg; H M Feder; G L Bell; P N Rys; D H Persing
Journal:  N Engl J Med       Date:  1992-12-17       Impact factor: 91.245

9.  Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans.

Authors:  J Nowakowski; R B Nadelman; G Forseter; D McKenna; G P Wormser
Journal:  J Am Acad Dermatol       Date:  1995-02       Impact factor: 11.527

10.  Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis.

Authors:  R J Dattwyler; D J Volkman; S M Conaty; S P Platkin; B J Luft
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321

View more
  9 in total

Review 1.  Antimicrobial prophylaxis.

Authors:  J Smith; A Finn
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 2.  Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.

Authors:  Daniel J Cameron; Lorraine B Johnson; Elizabeth L Maloney
Journal:  Expert Rev Anti Infect Ther       Date:  2014-07-30       Impact factor: 5.091

Review 3.  Tick-borne encephalopathies : epidemiology, diagnosis, treatment and prevention.

Authors:  Göran Günther; Mats Haglund
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Diagnosis, treatment, and prevention of Lyme disease in children.

Authors:  Stephen C Eppes
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 5.  [Lyme arthritis in children and adolescents].

Authors:  F Dressler; H-I Huppertz
Journal:  Z Rheumatol       Date:  2008-03       Impact factor: 1.372

6.  Sustained-release formulation of doxycycline hyclate for prophylaxis of tick bite infection in a murine model of Lyme borreliosis.

Authors:  N S Zeidner; K S Brandt; E Dadey; M C Dolan; C Happ; J Piesman
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

7.  Evaluation of the preventive capacities of a topically applied azithromycin formulation against Lyme borreliosis in a murine model.

Authors:  Jens Knauer; Inke Krupka; Christiane Fueldner; Joerg Lehmann; Reinhard K Straubinger
Journal:  J Antimicrob Chemother       Date:  2011-09-15       Impact factor: 5.790

Review 8.  Lyme disease and current aspects of immunization.

Authors:  Thomas Kamradt
Journal:  Arthritis Res       Date:  2001-09-28

9.  Lyme disease: clinical diagnosis and treatment.

Authors:  T F Hatchette; I Davis; B L Johnston
Journal:  Can Commun Dis Rep       Date:  2014-05-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.